SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-258677
Filing Date
2024-11-14
Accepted
2024-11-14 16:31:56
Documents
3
Group Members
LEE S. AINSLIE IIIMAVERICK CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d913111dsc13g.htm SC 13G 74014
2 EX-99.A d913111dex99a.htm EX-99.A 5314
3 EX-99.B d913111dex99b.htm EX-99.B 2976
  Complete submission text file 0001193125-24-258677.txt   83893
Mailing Address 1900 N. PEARL STREET, 20TH FLOOR DALLAS TX 75201
Business Address 1900 N. PEARL STREET, 20TH FLOOR DALLAS TX 75201 214.880.4050
MAVERICK CAPITAL LTD (Filed by) CIK: 0000934639 (see all company filings)

IRS No.: 000000000 | State of Incorp.: TX
Type: SC 13G

Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Subject) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89843 | Film No.: 241463229
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)